Menu

Day One Biopharmaceuticals, Inc. DAWN

Full chart Compare
Set alert

Price alert · DAWN

All alert types
21.53 USD 0.00 (+0.00%)

Apr 24, 2026, 9:30 AM EDT

21.53 Day range 21.53

52-week range unavailable

YTD
+131.01%
1 year
+172.53%

Revenue & Expenses

Other Income → Expenses: $18.45MIncome Tax Benefit → Expenses: $1.98MExpenses → Selling, General & Admin: $120.59MExpenses → Research & Development: $148.13MGross Profit → Expenses: $140.97MRevenue → Gross Profit: $140.97MRevenue → Cost of Revenue: $17.21MNet Loss → Expenses: $107.32MOther Income$18.45MIncome Tax Benefit$1.98MGross Profit$140.97MNet Loss$107.32MCost of Revenue$17.21MExpenses$268.72MSelling, General & Admin$120.59MResearch & Development$148.13MRevenue$158.18M

Latest period ending Dec 31, 2025 · select a line to chart its full history

Annual income statement

DAWN annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
158.18M131.16M000
158.18M131.16M000
17.21M5.28M000
140.97M125.88M000
268.72M343.15M206.06M146.91M72.74M
148.13M227.70M130.52M85.62M43.58M
120.59M115.45M75.54M61.29M29.16M
-127.75M-217.27M-206.06M-146.91M-72.74M
-1.98M7.14M000
-107.32M-95.50M-188.92M-142.18M-170.64M
-107.32M-95.50M-188.92M-142.18M-170.64M
-107.32M-95.50M-188.92M-142.18M-170.64M
-107.32M-95.50M-188.92M-142.18M-72.75M
-1.04-1.02-2.37-2.17-4.62
-1.04-1.02-2.37-2.17-4.62
-1.04-1.02-2.37-2.17-4.62
-109.30M-88.35M-188.92M-142.18M-170.64M
-109.30M-88.35M-188.92M-142.18M-170.64M
103.21M93.23M79.77M65.47M36.96M
103.21M93.23M79.77M65.47M36.96M